Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT03672110

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Technische Universität Dresden (from the registry)
Registry
  • NCT NCT03672110
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03672110. Randomized; no masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2020-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
Acronym
S&L
Condition
Renal Failure
Condition
Renal Insufficiency
Condition
Renal Disease
Condition
Renal Insufficiency, Chronic
Intervention (Drug)
Advagraf
Lead sponsor
Technische Universität Dresden (class: other)

Record details

Record id
cardio:ct-nct03672110
Content hash
dfef1a969c9bea3ff93256308ea611db06421109ab50ea296e66303393452a27